Wikipedia:Articles for deletion/C-KAD

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a deletion review
). No further edits should be made to this page.

The result was delete. ✗plicit 00:06, 26 May 2022 (UTC)[reply]

C-KAD

[Hide this box] New to Articles for deletion (AfD)? Read these primers!

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

I was unable to locate any sources from beyond 2008 of the this medicine. It appears the trials likely failed or have been discontinued Herravondure (talk) 23:19, 18 May 2022 (UTC)[reply]

Automated comment: This AfD was not correctly
Talk to my owner:Online 23:39, 18 May 2022 (UTC)[reply
]

Note: This discussion has been included in the list of Medicine-related deletion discussions. Spiderone^{(Talk to Spider)} 19:32, 19 May 2022 (UTC)[reply]

Delete No significant secondary independent coverage. All I found were based on press releases. Company website is dead https://chakshu.com/ . — rsjaffe 🗣️ 21:21, 19 May 2022 (UTC)[reply]

This possibly could redirect to Acetylcarnosine, as that appears to be the mysterious active ingredient, but I doubt anyone will be searching for C-KAD, and that redirect would be based upon some speculation as to what C-KAD really was. — rsjaffe 🗣️ 21:33, 19 May 2022 (UTC)[reply]

Good point. Also, there are other brand names under which N-acetylcarnosine eye drops are sold, e.g. Can-C. There have been a few clinical trials but overall, I agree there's no

WP:SIGCOV. Hence, Delete. Ari T. Benchaim (talk) 14:33, 20 May 2022 (UTC)[reply

]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review
). No further edits should be made to this page.